Research programme: conopeptide analgesics - CognetixAlternative Names: Conopeptide analgesics research programme - Cognetix
Latest Information Update: 29 Apr 2008
At a glance
- Originator University of Utah
- Developer Cognetix
- Class Conotoxins; Peptides
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain